Brief: Evaxion Biotech Says EVX-B1 Immunization Resulted In Complete Bacterial Clearance Of Staphylococcus Aureus In Multiple Organs
July 31 (Reuters) - Evaxion Biotech A/S EVAX.O :
* EVAXION PRESENTS PROMISING RESULTS ON EVX-B1, AN
AI-DESIGNED
VACCINE AGAINST STAPHYLOCOCCUS AUREUS
* EVAXION BIOTECH A/S - EVX-B1 IMMUNIZATION RESULTED IN
COMPLETE
BACTERIAL CLEARANCE OF S. AUREUS IN MULTIPLE ORGANS
Source text for Eikon: ID:nGNX75Y184
Further company coverage: EVAX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evaxion A/S
See all newsEvaxion A/S reports results for the quarter ended June 30 - Earnings Summary
Denmark's Evaxion Q2 net loss narrows on lower expenses
Brief: Evaxion Q2 Basic EPS USD -0.01
Evaxion A/S expected to post a loss of 31 cents a share - Earnings Preview
Brief: Evaxion A/S - Expands Pipeline Of Cancer Vaccine Programs With Evx-05 Against Brain Cancer Glioblastoma